TP53 and oral cavity carcinoma: To determine whether this expression is affected by tumor microenvironment, we surveyed p53 expression in 8 patient derived xenografts (PDX) from oropharyngeal and oral cavity carcinomas (four HPV16 positive and four negative) (45, 46).